Only then can pharmaceutical manufacturers pinpoint potential compliance risks and bottlenecks ... against chikungunya approved for use in the US, after Bavarian Nordic gets the green light ...

To maintain compliance with constantly shifting regulations, pharmaceutical companies need tools that enable them to discover, highlight, and extract key data within regulatory documents.

Simultaneously, Virpax Pharmaceuticals was granted an extension by the Nasdaq Hearings Panel to maintain its listing status, with a compliance deadline set for April 1, 2025. The company also made ...

Dublin, Feb. 13, 2025 (GLOBE NEWSWIRE) -- The "Mastering Pharmaceutical Document Management: Strategies for Compliance and Efficiency" training has been added to ResearchAndMarkets.com's offering.